Connect with us

Emerging Markets

Genesis Electronics Group, Inc. (OTCMKTS: GEGI) Major Blue Sky Breakout as Company Moves into Artificial intelligence AI, Autonomous Vehicles & Security Spaces

Published

on

Genesis Electronics Group, Inc. (OTCMKTS: GEGI) is rocketing up the charts on its way to easily top $1 million in dollar volume on the day and break out into copperland as the stock is under heavy accumulation and at the top of most otc traders watch lists. We first reported on GEGI in June when the stock was around $0.003 and it has rocketed up northbound since. There are a lot of exciting things happening at GEGI including the new CEO, business plan and website suggesting the Company is moving into the Artificial intelligence AI, autonomous vehicles, and security. All this comes after the Company cleared up a dispute with a former debtor of the Company which was preventing them from issuing any new shares and moving forward with their business plan. Also 89 million restricted shares have just been added to the OS suggesting there could be a significant acquisition in the works. 

Genesis Electronics Group, Inc. has been busy on twitter in recent days stating in August: We are excited to see pink current. It’s going to be a busy week.  We have a narrow focus.  Look for news to come. GEGI was able to secure two former consultants from KPMG and PWC to help advise and ensure GEGI is compliant with the markets. Their willingness to take stock is good evidence they believe in what we are putting together. More to come! The depth of this impactful movement we are a part of is gaining speed. It will move like a freight train. We are seeing it now as GEGI shares trade daily.  Offers for funding and strategic partner’s come to me regularly. I can accredit shareholders for much of this.  Thank you. Currently we are waiting on certain processes the will protect us and will ensure our partnerships with the elite will stick way into the future of Genises. Progress is being made; our focus is clear. I hope everyone has a fabulous weekend. Happy Saturday to the $GEGI team/shareholders. Moving forward, I will be speaking to you directly. We are very excited with all the developments taking place on our end. We look forward to sharing it with you all soon. Hope everyone has a good weekend. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Genesis Electronics Group, Inc. (OTCMKTS: GEGI) is assembling a team of autonomous experts to identify companies and/or technologies that can be acquired and applied to specific industries that are ripe for disruption. There is a lot happening with GEGI, the Company recently launched a new website (https://www.genesis-electronics.com/) That it will continue to evolve as its vision narrows within this industry. In addition, the Company has established a formal corporate Twitter account to better communicate with its shareholders and the public. That Twitter handle is: @GenesisElectro4. Genesis plans to file all of its required disclosures as soon as the OTC Markets completes their change of control process and allows access to the OTCiq system. At that time management anticipates all yield signs to be removed and for the Company to be current again. 

Following a debt restructuring as well as resolving a dispute with a former debtor of the Company leaving GEGI in position where it can now use its stock to look for exciting and new business ventures, Katharina Nanny Bahnsen announced her resignation as Chairwoman, CEO, and was replaced by incoming CEO Braden Jones. 

In May Genesis launched a new business plan focusing on acquisitions or license agreements with autonomous technology companies. The Company plans to focus on identifying companies and/or technologies in industries such as transportation, security, flight, and artificial intelligence where autonomous technologies will be an explosive accelerator to new business growth. New CEO Braden Jones said at the time: “I am very excited to finally be able to reveal the new focus for Genesis Electronics Group. Since I was appointed as CEO of the Company, there were a lot of corporate housekeeping items that needed to take place so that we can move forward with our business plan. The settlement with the past judgement holder was extremely valuable as it freed up the Company to actively grow the business and provide greater shareholder value. We have been working very hard to refine our business plan and we believe that focusing on autonomous technologies will bring the greatest value to our shareholders. Autonomous technology has rapidly advanced over the past 10 years and there are so many industries that can be disrupted if these technologies were applied to them. We are assembling a highly-qualified team of advisors and partners that are making introductions to companies that could be good candidates for acquisition or licensing agreements. Their expertise and guidance have been extremely valuable thus far. We look forward to formalizing our relationships with these individuals and the Company and making these announcements in the near future, so their value can be felt by our shareholders.” 

To Find out the inside Scoop on GEGI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

GEGI

According to Genesis new website: AUTONOMOUS TRANSPORTATION – The transportation industry is ripe for disruption. While many companies focus on autonomous cars and trucks, there is untapped potential where autonomous solutions can solve many logistics and transportation problems. 

AUTONOMOUS SECURITY – Autonomous solutions can drastically reduce costs and add much needed technology and support to current security solutions. Adding autonomous solutions to existing teams can increase efficiencies, decrease costs and save lives. 

ARTIFICIAL INTELLIGENCE – Autonomous solutions are only as good as the software and artificial intelligence behind the hardware. We are looking for tested and proven machine learning and artificial intelligence autonomous software that can be licensed or purchased to be leveraged in many applications. 

On June 22 GEGI announced It has signed an agreement to add Kevin Damoa as a strategic advisor to the Board. Mr. Damoa is an experienced Operations Professional and military veteran with a demonstrated history of working in the Aviation & Aerospace, Electrification, E-Mobility, and Defense industries. Mr. Damoa has held critical leadership positions at early start ups and well-established corporations. His history includes Flight Module Logistics Management at SpaceX, Integration Project Manager at Northrop Grumann, Vice President at Romeo Power Technology, Vice President at XOS Trucks, Logistics & Safety Director at Canoo, and VP of Operations at Serial 1 Cycle Company.  Mr. Damoa is skilled in Operations Management, Program/Project Management, Compliance Engineering , Logistics Operations, Team Building, Organizational Leadership, and Mechanical/Structural Design. 

Braden Jones, GEGI CEO stated at the time: “We are beyond thrilled to be able to add Kevin Damoa as a strategic advisor to Genesis Electronics Group. That someone of his caliber, expertise and experience sees the vision of what we are trying to accomplish and is willing to help us get there is huge! Kevin has so many skills that are critical in helping startups accelerate their path to success. His deep connections in the industry will be helpful in identifying companies to acquire, merge with or that has technology that can be licensed. Once that occurs, he will be extremely helpful in helping us build those businesses. The electric/autonomous industry is still relatively new and talent is expensive. It would cost us a lot of money to individually hire experts in each of the areas Kevin has experience with. We are very fortunate that he has accepted the role as strategic advisor.” 

For More on GEGI Subscribe Right Now!

Currently trading at a $14.5 million market valuation GEGI OS is 1,879,282,011 shares including the added 89 million restricted shares with just 307,072,424 shares in the float. GEGI does carry some debt on the books but not much at just under $2 million. GEGI is an exciting story developing in small caps, priced cheap with plenty of room for growth the stock is now running northbound on a blue sky breakout having eclipsed $0.0068 previous highs. There are a lot of exciting things happening at GEGI including the new CEO, business plan and website suggesting the Company is moving into the AI, autonomous vehicles, and security. All this comes after the Company cleared up a dispute with a former debtor of the Company which was preventing them from issuing any new shares and moving forward with their business plan. 89 million restricted shares have just been added to the OS suggesting there could be a significant acquisition in the works. GEGI recently brought on Kevin Damoa as a strategic advisor to the Board. Mr. Damoa is an experienced Operations Professional and military veteran with a demonstrated history of working in the Aviation & Aerospace, Electrification, E-Mobility, and Defense industries to help management execute on its new business plan. Microcapdaily first covered GEGI in June when the stock was around $0.003 and we will be covering GEGI so make sure you subscribe to Microcapdaily right now so you don’t miss it. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in GEGI either long or short and we have not been compensated for this article.

Emerging Markets

Strong Financials and Social Media Buzz Propel Forza X1, Inc. (NASDAQ:FRZA) to New Heights

Published

on

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023.

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023. This surge was accompanied by an unprecedented level of trading volume, marking a significant departure from the previously observed average. Notably, the stock’s trading volume had been relatively low in recent months, with numerous days experiencing trading activity of less than 1,000 shares. Without any apparent news or filings, the cause behind this sudden surge remains a subject of intrigue and speculation among market participants.

What happened?

Firstly it’s important to note that $FRZA is a spin-off of Twin Vee PowerCats Co. (Nasdaq: VEEE). $VEEE is the parent company handling the design, manufacturing, and distribution of recreational and commercial, off-shore power catamaran boats while $FRZA is the new developer of electric sport boats with a mission to accelerate the adoption of sustainable recreational boating.

To Discover the Inside Scoop on FRZA, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Upon examination of the company, no discernible filings or press releases have been identified to account for today’s remarkable shift. However, it seems that a tweet disseminated by the company caught the attention of retail investors, subsequently generating an enormous surge in trading volume.

This recent occurrence serves as yet another compelling demonstration of the significant impact that the retail community can exert when armed with information regarding a small float micro-cap stock, particularly when the conditions align favorably and validate the potential for substantial gains. The tweet, skillfully crafted by the company’s social media team, featured a compelling GIF and clever “Don’t miss the boat” blurb, demonstrating a keen understanding of their business’s essence. 

The timely and engaging content proved to be a perfect execution, capturing the attention and imagination of investors in a manner that resonated deeply with the nature of the company’s operations.

Overview of Twin Vee PowerCats Co. Financials

Could the surge in share price also reflect the market’s enthusiastic response to Twin Vee’s strong financial results for the first quarter of 2023? 

On May 15, 2023, Twin Vee PowerCats Co. released its financials demonstrating a substantial increase in net revenue and notable improvements in the gas-powered boat segment.

https://twitter.com/JohnZidar/status/1665685698400141313?s=20

Twin Vee PowerCats Co. (Nasdaq: VEEE) reported strong financial results for the first quarter ended March 31, 2023. The company experienced a notable 51% increase in net revenue, reaching $8.9 million compared to $5.9 million in the same period last year. The gas-powered boat segment achieved a net income of $181,000, significantly improving from the net loss of $626,000 in Q1 2022.

However, as per GAAP accounting policy, Twin Vee’s consolidated financial statements resulted in a total net loss of $1.8 million for the quarter, primarily due to their majority ownership in Forza X1, Inc. (Nasdaq: FRZA), an electric boat company. Twin Vee reported cash, cash equivalents, restricted cash, and marketable securities of approximately $12.6 million as of March 31, 2023.

The company has been expanding its product lineup, including introducing the Aquasport mono-hull boat brand. Twin Vee is confident these efforts will contribute to business scalability and brand growth. They aim to optimize inventory levels and production costs while closely monitoring market conditions, dealer inventories, and economic indicators.

Financial highlights for Q1 2023

  • Total revenue: $8,877,000 (51% increase compared to Q1 2022)
  • Gross profit: $3,222,000
  • Net income from gas-powered boats segment: $182,000
  • Net loss from Forza X1 (electric boat entity): $2,005,000
  • Loss from Fix My Boat (franchise business): $5,000
  • Adjusted net loss (excluding non-cash charges): $1,347,000
  • Adjusted net income from gas-powered boats segment: $265,000

Twin Vee’s consolidated cash, cash equivalents, restricted cash, and marketable securities were $23,457,000 as of March 31, 2023. Forza X1 reported $10,683,000 in the same category, while Twin Vee’s core business had $12,643,000, and Fix My Boat had approximately $132,000.

We will closely monitor the performance of Forza X1, Inc. (Nasdaq: FRZA) in the coming weeks, considering that it is a spinoff from its parent company. It is crucial to conduct thorough research, particularly for companies like FRZA that have yet to achieve profitability. However, it is worth noting that the parent company has been making notable progress, as evidenced by its recent financial results, which revealed a substantial increase in the bottom line.

We will update you on FRZA when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Sasin Tipchai from Pixabay

Continue Reading

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.